Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Classical hematology 10Breast 4Thoracic 1Other hematologic neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 13138Triple Negative Breast Neoplasms 1150Neoplasms 750Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 581Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 536Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 204Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Interventions

pegfilgrastim 1MYL-1401H 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Chemotherapy-Induced Febrile Neutropenia × Breast × Clear all
NCT06616571 2024-09-27

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

Qilu Pharmaceutical Co., Ltd.

Phase 4 Recruiting
336 enrolled
BreastClassical hematology

Breast Neoplasms, Chemotherapy-Induced Febrile Neutropenia, Febrile Neutropenia

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

Viatris Inc.

Phase 3 Completed
193 enrolled
BreastClassical hematology

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT02178475 2018-07-23

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Amgen

Completed
943 enrolled 28 charts
BreastClassical hematology

Breast Neoplasms, Chemotherapy-Induced Febrile Neutropenia

NCT01813721 2017-03-15

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Amgen

Completed
1,007 enrolled 9 charts
BreastClassical hematologyThoracic

Breast Neoplasms, Lung Neoplasms, Chemotherapy-Induced Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡